Research map: Ki-67 Expression in megakaryocytes: A new prognostic marker in Myelodysplastic Syndromes

Back to the article

Papers in this map

  1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia · Daniel A. Arber · 2016 · 10386 citations · Cited by this paper
  2. Clinicopathological analysis of 21 cases of “Synchronous” endocervical and ovarian adenocarcinomas · 2026 · Related
  3. The Ki-67 protein: From the known and the unknown · Thomas E. Scholzen · 2000 · 4722 citations · Cited by this paper
  4. Combined inverted follicular keratosis and adnexal tumors: a series of 12 cases · 2026 · Related
  5. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes · James W. Vardiman · 2009 · 4459 citations · Cited by this paper
  6. Clinicopathological features and risk stratification for lymph node metastasis in early-stage colorectal cancer (from intramucosal carcinoma to SM2): a large-scale retrospective study based on a Chinese population · 2026 · Related
  7. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms · Joseph David Khoury · 2022 · 4220 citations · Cited by this paper
  8. High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images · 2026 · Related
  9. Clinical and biological implications of driver mutations in myelodysplastic syndromes · Elli Papaemmanuil · 2013 · 1864 citations · Cited by this paper
  10. ASPSCR1::TFE3-rearranged renal cell carcinomas: clinicopathologic, molecular, and survival analysis of 30 cases · 2026 · Related
  11. Molecular International Prognostic Scoring System for Myelodysplastic Syndromes · Elsa Bernard · 2022 · 863 citations · Cited by this paper
  12. MYD88L265P mutation is a highly specific marker for the nonGCB/ABC DLBCL molecular subtype · 2026 · Related
  13. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion · Ingmar Bruns · 2014 · 626 citations · Cited by this paper
  14. Immune-related pathologic response (irPR) features and immunotherapeutic response score (ITRS) predict survival following neoadjuvant/conversion combined immunotherapy in intrahepatic cholangiocarcinoma · 2026 · Related
  15. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference · Peter Valent · 2007 · 512 citations · Cited by this paper
  16. GPR143, a novel immunohistochemical marker for renal tumors with FLCN/TSC/MTOR-TFE alterations · 2026 · Related
  17. Ki67 protein: the immaculate deception? · D C Brown · 2002 · 508 citations · Cited by this paper
  18. Sarcomatous transformation of an astrocytoma IDH-mutant following radiotherapy · 2026 · Related
  19. Myelodysplastic Syndromes · Mario Cazzola · 2020 · 508 citations · Cited by this paper
  20. Low-grade fibromyxoid sarcoma in abdominopelvic and retroperitoneal locations: a clinicopathologic analysis of 26 cases and a review of the literature · 2026 · Related
  21. The Ki-67 Protein: Fascinating Forms and an Unknown Function · Elmar Endl · 2000 · 382 citations · Cited by this paper
  22. Clinical consequences of clonal hematopoiesis of indeterminate potential · David P. Steensma · 2018 · 197 citations · Cited by this paper
  23. Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin · Ayako Nakamura‐Ishizu · 2014 · 165 citations · Cited by this paper
  24. CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow · Ayako Nakamura‐Ishizu · 2015 · 127 citations · Cited by this paper
  25. Myelodysplastic syndromes · Huan Li · 2022 · 87 citations · Cited by this paper
  26. Current therapy of myelodysplastic syndromes · Amer Methqal Zeidan · 2013 · 86 citations · Cited by this paper
  27. Antiangiogenesis in haematological malignancies · William W. Li · 2008 · 66 citations · Cited by this paper
  28. Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes · Hans‐Peter Horny · 2007 · 53 citations · Cited by this paper
  29. Reference standards for bone marrow cellularity · Nükhet Tüzüner · 1994 · 40 citations · Cited by this paper
  30. Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia · Melania Tesio · 2017 · 36 citations · Cited by this paper
  31. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections · Wilma Pellegrini · 1995 · 31 citations · Cited by this paper
  32. Have we reached a molecular era in myelodysplastic syndromes? · Maria Teresa Voso · 2021 · 29 citations · Cited by this paper
  33. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes · Guilin Tang · 2011 · 25 citations · Cited by this paper
  34. Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes · Michael G. Alexandrakis · 2004 · 18 citations · Cited by this paper
  35. Myelodysplastic syndromes in S outh A merica: A multinational study of 1080 patients · Carolina Belli · 2015 · 18 citations · Cited by this paper
  36. Integration of the Ki-67 proliferation index into the Ogata score improves its diagnostic sensitivity for low-grade myelodysplastic syndromes · Stefan G.C. Mestrum · 2022 · 16 citations · Cited by this paper
  37. Myelodysplastic syndromes in Latin America: state of the art · Renée Leonor Crisp · 2018 · 5 citations · Cited by this paper
  38. Age, Blasts, Performance Status and Lenalidomide Therapy Influence the Outcome of Myelodysplastic Syndrome With Isolated Del(5q): A Study of 58 South American Patients · RS Azevedo · 2021 · 5 citations · Cited by this paper
  39. Bone marrow niches in myelodysplastic syndromes · Giovanna Tosato · 2021 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)